Literature DB >> 19703937

Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex.

Stephen M Eggan1, Yoshito Mizoguchi, Samuel R Stoyak, David A Lewis.   

Abstract

Adolescent cannabis use is associated with an increased risk of schizophrenia and with impairments in cognitive processes reliant on the circuitry of the dorsolateral prefrontal cortex (DLPFC). Additionally, maternal cannabis use is associated with cognitive dysfunction in offspring. The effects of cannabis are mediated by the cannabinoid 1 receptor (CB1R), which is present in high density in the primate DLPFC. In order to determine how developmental changes in CB1Rs might render DLPFC circuitry vulnerable to cannabis exposure, we examined the density and innervation patterns of CB1R-immunoreactive (IR) axons and the expression of CB1R mRNA in the DLPFC from 81 macaque monkeys, ranging in age from embryonic 82 days to 18 years. Overall CB1R immunoreactivity in the gray matter robustly increased during the perinatal period and achieved adult levels by 1 week postnatal. However, laminar analyses revealed that CB1R-IR axon density significantly decreased with age in layers 1-2 but significantly increased in layer 4, especially during adolescence. In contrast, CB1R mRNA levels were highest 1 week postnatal, declined over the next 2 months, and then remained unchanged into adulthood. These findings provide a potential substrate for discrete, age-dependent effects of cannabis exposure on the maturation of primate DLPFC circuitry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703937      PMCID: PMC2852503          DOI: 10.1093/cercor/bhp179

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  71 in total

1.  Cell type-specific gating of perisomatic inhibition by cholecystokinin.

Authors:  Csaba Földy; Soo Yeun Lee; János Szabadics; Axel Neu; Ivan Soltesz
Journal:  Nat Neurosci       Date:  2007-08-05       Impact factor: 24.884

2.  GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex.

Authors:  Bidisha Chattopadhyaya; Graziella Di Cristo; Cai Zhi Wu; Graham Knott; Sandra Kuhlman; Yu Fu; Richard D Palmiter; Z Josh Huang
Journal:  Neuron       Date:  2007-06-21       Impact factor: 17.173

3.  Hardwiring the brain: endocannabinoids shape neuronal connectivity.

Authors:  Paul Berghuis; Ann M Rajnicek; Yury M Morozov; Ruth A Ross; Jan Mulder; Gabriella M Urbán; Krisztina Monory; Giovanni Marsicano; Michela Matteoli; Alison Canty; Andrew J Irving; István Katona; Yuchio Yanagawa; Pasko Rakic; Beat Lutz; Ken Mackie; Tibor Harkany
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

Review 4.  Cannabis, the mind and society: the hash realities.

Authors:  Robin M Murray; Paul D Morrison; Cécile Henquet; Marta Di Forti
Journal:  Nat Rev Neurosci       Date:  2007-11       Impact factor: 34.870

5.  Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex.

Authors:  S Deshmukh; K Onozuka; K J Bender; V A Bender; B Lutz; K Mackie; D E Feldman
Journal:  Neuroscience       Date:  2007-01-08       Impact factor: 3.590

6.  Postnatal alterations in dopaminergic markers in the human prefrontal cortex.

Authors:  C S Weickert; M J Webster; P Gondipalli; D Rothmond; R J Fatula; M M Herman; J E Kleinman; M Akil
Journal:  Neuroscience       Date:  2006-11-22       Impact factor: 3.590

7.  Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex.

Authors:  Eugene Carter; Xiao-Jing Wang
Journal:  Cereb Cortex       Date:  2007-09       Impact factor: 5.357

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

9.  Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.

Authors:  Stephen M Eggan; David A Lewis
Journal:  Cereb Cortex       Date:  2006-02-08       Impact factor: 5.357

10.  Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.

Authors:  Miranda A Karson; Kevin C Whittington; Bradley E Alger
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

View more
  24 in total

1.  Development of sensory gamma oscillations and cross-frequency coupling from childhood to early adulthood.

Authors:  Raymond Y Cho; Christopher P Walker; Nicola R Polizzotto; Thomas A Wozny; Catherine Fissell; Chi-Ming A Chen; David A Lewis
Journal:  Cereb Cortex       Date:  2013-12-10       Impact factor: 5.357

2.  Cortical opioid markers in schizophrenia and across postnatal development.

Authors:  David W Volk; Polina V Radchenkova; Erin M Walker; Elizabeth J Sengupta; David A Lewis
Journal:  Cereb Cortex       Date:  2011-08-01       Impact factor: 5.357

Review 3.  Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes.

Authors:  Heather C Brenhouse; Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2011-05-12       Impact factor: 8.989

Review 4.  Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Authors:  Daniel T Malone; Matthew N Hill; Tiziana Rubino
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  Synaptic functions of endocannabinoid signaling in health and disease.

Authors:  Alfonso Araque; Pablo E Castillo; Olivier J Manzoni; Raffaella Tonini
Journal:  Neuropharmacology       Date:  2017-06-15       Impact factor: 5.250

Review 6.  Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Authors:  Atsushi Saito; Michael D L Ballinger; Mikhail V Pletnikov; Dean F Wong; Atsushi Kamiya
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

7.  Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory.

Authors:  Christopher D Verrico; Hong Gu; Melanie L Peterson; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2014-04       Impact factor: 18.112

8.  Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.

Authors:  D E Evans; S K Sutton; K G Jentink; H-Y Lin; J Y Park; D J Drobes
Journal:  Genes Brain Behav       Date:  2016-09       Impact factor: 3.449

Review 9.  The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-06-19       Impact factor: 13.382

10.  Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.

Authors:  Sylvina M Raver; Asaf Keller
Journal:  Neuropharmacology       Date:  2014-07-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.